Circuit Clinical, one of the nation’s largest integrated research organizations dedicated to empowering patients to choose clinical research as a care option, announced a groundbreaking strategic partnership with CUBRC, a company specializing in advanced data analytics, information fusion and biomedical sciences.
The agreement will combine both Circuit Clinical’s unique physician network and TrialScout™, a first-of-its-kind patient engagement platform, with CUBRC’s expertise in data sciences and the development and deployment of analytical software tools.
“This remarkable partnership completes Circuit Clinical’s comprehensive offering for creating and catalyzing the deep life science dataset that’s needed to drive the discovery of new medicines,” said Dr. Irfan Khan, CEO of Circuit Clinical. “With our foundational commitment to patient privacy and data ownership, our Physician Network partners and TrialScout already enable us to directly engage patients who are interested in donating their genomic and health data in a transparent and empowering manner. Our recently announced partnership with University at Buffalo Biorepository provides Circuit Clinical with the ability to sequence and store these donated biosamples. Now our collaboration with CUBRC will let us analyze all of the datasets we collect using a state-of-the-art HIPAA-compliant platform and an expert data science team as partners. This is a bold new approach for driving the discovery of new medicines.”
The strategic partnership is expected to:
Provide Circuit Clinical access to CUBRC’s Heartwood Analytics machine learning platform to drive new insights and potential targets for drug discovery; Enable Circuit Clinical and CUBRC to partner on novel NIH and DoD data science projects in healthcare and information technology; and Complete the population health capabilities of Circuit Clinical as it addresses building scaled collections of clinical and genomic life science datasets.
CUBRC’s healthcare informatics team, led by Dr. John Coles, is collaborating with physicians, insurers, and medical device manufacturers to develop innovative predictive analytic methods designed to improve patient outcomes while managing cost. “This partnership will enable CUBRC to apply its machine learning and artificial intelligence platforms to sets to provide high-confidence predictions of overall efficacy and individual patient response to new therapies,” said Mike Moskal, CUBRC’s CIO and Senior Vice President of the Information Exploitation Sector.
CUBRC is an independent not-for-profit research and development company specializing in the areas of Chemical, Biological and Medical Defense, Biological Sciences, Data Science and Information Fusion and Aeronautics. CUBRC has over 30 years of experience combining innovative ideas and state-of-the-art technology and test facilities to help solve some of the most critical and challenging problems facing our nation. CUBRC’s mission is to make a significant, positive technological and economic impact to Western New York and New York State. CUBRC is headquartered in Buffalo, New York.
About Circuit Clinical
Circuit Clinical, one of the largest integrated research organizations [IRO] in the US, and through its Web site www.TrialScout.com, is dedicated to empowering patients choosing clinical research as a care option. Born from the experiences of a physician conducting clinical research in his busy private practice in 2015, Circuit Clinical and its team are committed to transforming the physician and participant engagement by helping patients participating in clinical trials with turnkey clinical research services and patient platform. Since its founding in 2015, Circuit Clinical has built HIPAA/FDA-compliant Electronic Medical Record (EMR) review. Coupled with technology products that enhance the participant and physician experience, Circuit Clinical provides a new path forward in clinical research to its network of more than one million patients, physicians, and sponsor partners.